| ARCHETYPE ID | openEHR-EHR-OBSERVATION.neurologic_assessment_in_neuro_oncology_scale.v0 |
|---|---|
| Concept | Neurologic Assessment in Neuro-Oncology (NANO) scale |
| Description | The NANO scale is a tool for assessing neurologic function in patients with brain tumor. |
| Use | Use to record the result for each component parameter for the NANO-scale. The ordinal value '99' is included to represent the non-numerical values 'Not assessed' and 'Not evaluable'. Neither current modelling tools nor any current implementations allow using a combination of numerical and non-numerical values within a single value set. |
| Purpose | To record the result for each component parameter for the NANO-scale. |
| References | Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J, Jaeckle K, Mehta M, Stupp R, Muzikansky A, Pentsova E, Cloughesy T, Iwamoto FM, Tonn JC, Vogelbaum MA, Wen PY, van den Bent MJ, Reardon DA. The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. Neuro Oncol. 2017 May 1;19(5):625-635. doi: 10.1093/neuonc/nox029. Review. PubMed PMID: 28453751; PubMed Central PMCID: PMC5464449. |
| Copyright | © openEHR Foundation, Nasjonal IKT HF, openEHR Foundation |
| Authors | Author name: Bjørn Næss Organisation: DIPS AS Email: bna@dips.no Date originally authored: 2023-04-21 |
| Other Details Language | Author name: Bjørn Næss Organisation: DIPS AS Email: bna@dips.no Date originally authored: 2023-04-21 |
| Other Details (Language Independent) |
|
| Keywords | neurologic function, NANO, brain tumor, assessment, CNS, neuro-oncology, outcome |
| Lifecycle | in_development |
| UID | 2e902458-f7f3-4a71-9c92-c69c5fe5a91c |
| Language used | en |
| Citeable Identifier | 1013.1.7080 |
| Revision Number | 0.0.1-alpha |
| events | |
| Any event | Any event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time. |
| data | |
| Gait | Gait: 0: Normal 1: Abnormal but walks without assistance 2: Abnormal and requires assistance (companion, cane, walker, etc.) 3: Unable to walk 99: Not assessed 99: Not evaluable |
| Strength | Strength: 0: Normal 1: Movement present but decreased against resistance 2: Movement present but none against resistance 3: No movement 99: Not assessed 99: Not evaluable |
| Ataxia(upper extremity) | Ataxia(upper extremity): 0: Able to finger to nose touch without difficulty 1: Able to finger to nose touch but difficult 2: Unable to finger to nose touch 99: Not assessed 99: Not evaluable |
| Sensation | Sensation: 0: Normal 1: Decreased but aware of sensory modality 2: Unaware of sensory modality 99: Not assessed 99: Not evaluable |
| Visual fields | Visual fields: 0: Normal 1: Inconsistent or equivocal partial hemianopsia (≥ quadrantopsia) 2: Consistent or unequivocal partial hemianopsia (≥ quadrantopsia) 3: Complete hemianopsia 99: Not assessed 99: Not evaluable |
| Facial strength | Facial strength: 0: Normal 1: Mild/moderate weakness 2: Severe facial weakness 99: Not assessed 99: Not evaluable |
| Language | Language: 0: Normal 1: Abnormal but easily conveys meaning to examiner [Includes word finding difficulty; few paraphasic errors/neologisms/word substitutions; but able to form sentences (full/broken).] 2: Abnormal and difficulty conveying meaning to examiner [Includes inability to form sentences (<4 words per phrase/sentence); limited word output; fluent but "empty" speech.] 3: Abnormal. If verbal, unable to convey meaning to the examiner OR non-verbal (mute/global aphasia) 99: Not assessed 99: Not evaluable |
| Level of consciousness | Level of consciousness: 0: Normal 1: Drowsy (easily arousable) 2: Somnolent (difficult to arouse) 3: Unarousable/coma 99: Not assessed 99: Not evaluable |
| Behavior | Behavior: 0: Normal 1: Mild/moderate alteration 2: Severe alteration 99: Not assessed 99: Not evaluable |
| protocol | |
| Additional details | Additional details: Additional information required to extend the model with local content or to align with other reference models or formalisms. For example: local information requirements; or additional metadata to align with FHIR. Include: All not explicitly excluded archetypes |
| Other contributors | |
| Translators |